Skip to main content
Caplight Logo









EviCure

EviCure

Private
Ness ZionaHealthcare & Life Scienceshttps://www.evicure.bio/

Last Round

Seed

May 15, 2023

Company Overview

EviCure is a biotechnology company that develops an artificial intelligence-driven platform for the production of extracellular vesicle-based therapies to treat solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

extracellular vesicleEV therapeuticscancer drug deliverynon-small cell lung cancerNSCLCtargeted cancer therapydrug delivery platformbiotech drug discoveryexosome therapyAI drug discoveryprecision oncologysolid tumor treatmentbiomanufacturingin silico drug designnext-gen biologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EviCure Comparables

Compare EviCure with similar companies based on industry and business-model similarity.

EviCure comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vanquish Bio
79%
ExoVectory
78%
ILIAS Biologics Inc.
77%

EviCure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 15, 2023

Key People

Founding team and executive leadership

Eric J. Messika

Chief Executive Officer

Executive Team

EviCure Investors

Notable investors and investment history

EviCure investors
InvestorRounds
Peregrine VenturesVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2023

    Peregrine Ventures led the Seed round.

EviCure Filings

Explore SEC and related filing metadata, where available.

EviCure filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EviCure's valuation, stock price, and market status.

Is EviCure a public or private company?

EviCure is a private company.

What is the current stock price of EviCure?

EviCure is a private company with no public stock price. Caplight tracks EviCure's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is EviCure worth (valuation)?

Valuation information for EviCure is not publicly available.

Can I buy EviCure stock?

EviCure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EviCure's last funding round?

EviCure's most recent funding round was Seed on May 15, 2023.

Who are the main investors in EviCure?

Key investors in EviCure include Peregrine Ventures.

Will EviCure IPO soon?

No public IPO plans have been announced for EviCure.

How can I track EviCure secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EviCure's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNess Ziona
Employee Range3
Year Founded2023
Last FundingMay 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?